Cargando…
Oligomers Are Promising Targets for Drug Development in the Treatment of Proteinopathies
Currently, there is no effective treatment of proteinopathies, as well as their diagnosis in the early stages of the disease until the first clinical symptoms appear. The proposed model of fibrillation of the Aβ peptide and its fragments not only describes molecular rearrangements, but also offers m...
Autor principal: | Galzitskaya, Oxana V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7006448/ https://www.ncbi.nlm.nih.gov/pubmed/32076398 http://dx.doi.org/10.3389/fnmol.2019.00319 |
Ejemplares similares
-
Gamma-Carbolines Derivatives As Promising Agents for the Development of Pathogenic Therapy for Proteinopathy
por: Skvortsova, V. I., et al.
Publicado: (2018) -
Altered Mitochondrial Protein Homeostasis and Proteinopathies
por: Jishi, Aya, et al.
Publicado: (2022) -
Editorial: Translational imaging in neurodegenerative proteinopathies
por: Ni, Ruiqing, et al.
Publicado: (2022) -
Editorial: Mechanisms of Action in Neurodegenerative Proteinopathies
por: Miller, Sean J., et al.
Publicado: (2022) -
Trapping the oligomers: new promises in neurosciences
por: Imberdis, Thibaut, et al.
Publicado: (2016)